Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Medical Malpractice Law & StrategyLJN NewslettersNewsSections

Drug & Device News

By ALM Staff | Law Journal Newsletters |
February 28, 2011

FDA to Streamline Common Review Path for Medical Devices

The Food and Drug Administration (FDA) announced Jan. 19 that it intends to implement a new 25-point plan to improve the path to market for certain medical device products. The system will include a new Center Science Council made up of senior FDA experts whose job will be to ensure timely and consistent science-based decision-making. Under the new plan, de novo review of some innovative, lower risk medical devices will also be streamlined. The changes to the submission process for 510(k)s (so-called for the section of the Federal Food, Drug, and Cosmetic Act that describes this process) are being implemented because industry players working to obtain pre-market approval for low-risk devices (such as catheters and diagnostic imaging tools) found the old system unpredictable and confusing. Consumers and health care providers criticized approvals under the old system for not being rigorous enough. Jeffrey Shuren, M.D., J.D., director of the FDA's Center for Devices and Radiological Health (CDRH), says the planned changes will create “a smarter medical device program that supports innovation, keeps jobs here at home, and brings important, safe, and effective technologies to patients quickly.” For more information on specific changes to the approval process, go to: http://www.fda.gov/About
FDA/CentersOffices/CDRH/CDRH Reports/ucm239448.htm

This premium content is locked for LJN Newsletters subscribers only

  • Stay current on the latest information, rulings, regulations, and trends
  • Includes practical, must-have information on copyrights, royalties, AI, and more
  • Tap into expert guidance from top entertainment lawyers and experts

For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473

Read These Next
The DOJ's Corporate Enforcement Policy: One Year Later Image

The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.

The DOJ's New Parameters for Evaluating Corporate Compliance Programs Image

The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.

Use of Deferred Prosecution Agreements In White Collar Investigations Image

This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.

A Lawyer's System for Active Reading Image

Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.

Bankruptcy Sales: Finding a Diamond In the Rough Image

There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.